Can a Blood Test Help Predict Who Is at Risk for Colorectal Cancer?. Ann Intern Med. 2005;142:I-79. doi: 10.7326/0003-4819-142-6-200503150-00004
Download citation file:
Published: Ann Intern Med. 2005;142(6):I-79.
Colorectal cancer is a leading cause of cancer and of death from cancer in the United States. Risk factors include physical inactivity, a low-fiber diet, and having a family member with this type of cancer. Some data suggest that low-grade inflammation may also increase the risk for colorectal cancer. C-reactive protein (CRP) is a protein in the blood that increases when inflammation is present in the body. If inflammation increases a person's risk for developing colorectal cancer, higher CRP levels might be a sign of that higher risk.
To see whether CRP levels in the blood predict a person's risk for developing colorectal cancer.
27,913 women health professionals 45 years of age or older. None had ever had cancer or heart disease. All were participants in the Women's Health Study, a trial begun in 1993 to see whether aspirin and vitamin E prevent cancer and heart disease.
The researchers took blood samples for CRP testing at the beginning of the study. They sent questionnaires to participants every year for the next 10 years. The questionnaires asked women about their health and whether they had developed colorectal cancer in the preceding year. The researchers then compared the women's risk for developing colorectal cancer according to whether they had had a low, intermediate, or high CRP level.
Women reported 169 instances of colorectal cancer, which were confirmed by review of medical records. Women with low CRP levels were just as likely as those with higher levels to develop colorectal cancer. CRP levels also did not predict which women had smaller tumors and which had larger tumors or more advanced cancer.
The participants were female health professionals. We do not know whether men or patients with chronic conditions would have similar findings. A single baseline CRP measurement may be an imperfect marker of inflammation. Relying on a woman's report of cancer rather than routinely using tests to detect lesions may have missed some cases of cancer.
Higher CRP levels probably do not predict higher risk for colorectal cancer in healthy women. The finding implies that inflammation may not be a significant risk factor for colorectal cancer. Doctors will need to find ways other than measuring CRP levels to predict who is likely to develop colorectal cancer.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Gastroenterology/Hepatology, Hematology/Oncology, Gastrointestinal Cancer, Colorectal Cancer.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only